HB
Hamlet Biopharma AB (publ) Stock: price and insider trades · Sweden
Hamlet Biopharma AB (publ): what insiders have been doing
Only a handful of insider records exist for Hamlet Biopharma AB (publ), the last one from 3 August 2026, too few to describe a trend. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
1 ops. · all time
Who traded when
BuySaleHenrik Sundin1 sale
Financial data
· cache
Last declaration on 3 August 2026
Declarations1 total
- 237,120 shares0TeckningsoptionFI:csv-c3f494f2faae37f416e1
1 of 1 declaration
About Hamlet Biopharma AB (publ)
Hamlet Biopharma AB (publ) is a Swedish biopharmaceutical company listed on the Stockholm Stock Exchange. It focuses on developing innovative treatments for cancer.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations